The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Myles latest offering:
https://twitter.com/MylesMcNulty/status/1261614278211252225
so thats Ā£50 a share roughly - pretty sure thats an offer no one would refuse.
I did see some twitter chat between Myles and someone else where he did actually muse a price:
I don't have a specific investment horizon, but ideally I'll hold #AVCT until at least the first TMAC molecule has gone through Phase I trials.
I had thought that this would be 2022 (so end 2022 for results), but I now believe that TMAC could go into Phase I without... 1/2
..the need for a standalone Phase I trial for the Affimer tech (i.e. PD-L1) first. That is, the 1st trial for a TMAC molecule could follow straight after a successful Phase I trial for pro-dox. So potentially early 2022 for TMAC results.
Success there, and I'd want Ā£20 #AVCT 2/2
Important to add this was May 1st before it became possible/probable that we were on a profit share rather than a royalty with Cytiva and yesterdays news of course.
oh joy - just a 50% increase in number of shares. joke.
hinton88 - 15th November 2018
BBN
@BigBiteNow
So the commercial rights means that #AVCT will either license the product to 3rd parties or they will go direct to distributors with the product having their own name on it.
The hints were there that is wasn't just a royalty deal with Cytiva.
Sensational.
Myles McNulty
@MylesMcNulty
Ā·
1h
Replying to
@BigBiteNow
You might well have been correct all along,
@BigBiteNow
!
If Cytiva is just operating as manufacturer for us, we'll secure a massive chunk of the gross profit.
Truly sensational.
15 November 2018
N4 Pharma Plc
("N4 Pharma" or the "Company")
Filing of further NuvecĀ® patent application
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing a novel delivery system for vaccines and cancer treatments, is pleased to announce the filing of its Patent Cooperation Treaty ("PCT") patent application for its novel delivery system, NuvecĀ®.
NuvecĀ® is licensed by the Company from the University of Queensland under their silica nanoparticle patent application, which is currently under prosecution before various national patent offices. The patent application that was filed by the Company is based on improvements made to the manufacturing process, as the Company has scaled up production alongside specific examples of how NuvecĀ® can be used to improve delivery of nucleic acids.
The Company's new PCT patent application claims priority from the Company's United Kingdom patent application number 1718817.8. The PCT application will publish approximately 18 months from the priority date of 14 November 2017. Therefore publication is expected on or shortly after 14 May 2019. National phase entry is due 30 months from the priority date, in most countries. The national phasing deadline is therefore expected to be 14 May 2020.
i think you will find N4p have a number of patents filed re Nuvec going back some years now, unless i am very much mistaken.
08:28:22 30-Apr-2020 86.50 GBX 50,000 43,250.00 Off-book LRGS AIMX
10:53:28 30-Apr-2020 92.00 GBX 163,044 150,000.48 Off-book LRGS AIMX
09:19:30 30-Apr-2020 92.70 GBX 100,000 92,700.00 Off-book LRGS AIMX
08:13:00 30-Apr-2020 93.25 GBX 50,000 46,625.00 Off-book LRGS AIMX
08:10:45 30-Apr-2020 94.00 GBX 48,343 45,442.42 Off-book LRGS AIMX
08:27:44 30-Apr-2020 90.00 GBX 50,000 45,000.00 Off-book LRGS AIMX
10:59:11 30-Apr-2020 93.50 GBX 119,402 111,640.87 Off-book LRGS AIMX
08:12:42 30-Apr-2020 94.20 GBX 86,802 81,767.48 Off-book LRGS AIMX
08:11:17 30-Apr-2020 93.00 GBX 100,000 93,000.00 Off-book LRGS AIMX
13:59:01 30-Apr-2020 99.00 GBX 50,000 49,500.00 Off-book LRGS AIMX
well if you have been buying over the last 2.5 years your average should be pretty low -so every chance you will make money . I have 270k at average 12p in a sipp and 55k in an isa averaging 17p i think. so i have a long way to go to even break even!!
i used to think this was gonna be a life changer share (Ā£3-5 ps). Aim chaos/Myles McNulty had about 5m shares or something
ridiculous. Another individual had 12m i think!! I would be very happy if it got to 50p and delighted with a quid!